Press Releases Archives - Page 26 of 103 - Lupin

BSE 2296.40 NSE 2298.80

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2296.40 NSE 2298.80

Lupin’s Alliance Partner Caplin Receives U.S. FDA Approval for Thiamine Hydrochloride Injection USP

Lupin Digital Health Unveils Results of India’s First Digital Therapeutics Study with ACS Patients

Lupin Bio research Centre Completes U.S. FDA Inspection with No Observations

U.S. FDA Completes Inspection of Lupin’s Vizag Facility with No Observations

Lupin Diagnostics Expands Presence in South India with New Regional Reference Laboratory in Hyderabad

Lupin Launches Lurasidone Hydrochloride Tablets in the United States

February 21, 2023

Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur

February 17, 2023

Lupin’s Aptivate Champion Run for Kids Receives Overwhelming Support

February 14, 2023

Lupin Launches Atharv Ability – State-of-the-Art, Multi-Disciplinary Neuro-Rehabilitation Center in Mumbai

February 14, 2023

Lupin Q3 FY2023 Results

February 9, 2023

1 2 … 25 26 27 … 102 103

Search

Hit enter to search or ESC to close